Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liver transplantation--present and future].

Koji Umeshita1, Morito Monden

  • 1Department of Surgery, Osaka University Graduate School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver Transplantation in Japan: Registry by the Japanese Liver Transplantation Society.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same author

Liver transplantation for gastroenteropancreatic neuroendocrine liver metastasis: optimal patient selection and perioperative management in the era of multimodal treatments.

Journal of gastroenterology·2024
Same author

Improved survival of pediatric deceased donor liver transplantation recipients after introduction of the pediatric prioritization system: Analysis of data from a Japanese national survey.

Journal of hepato-biliary-pancreatic sciences·2024
Same author

Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study.

BJS open·2024
Same author

Challenges in decision-making support processes regarding living kidney donation: A qualitative study.

Journal of renal care·2024
Same author

An Analysis of 10,000 Cases of Living Donor Liver Transplantation in Japan: Special Reference to the Graft-Versus-Recipient Weight Ratio and Donor Age.

Annals of surgery·2023
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Liver transplant outcomes for hepatitis B have improved with new treatments. However, preventing hepatitis C recurrence and improving outcomes for ABO-incompatible transplants require further research and donor availability.

Area of Science:

  • Hepatology
  • Transplantation Immunology
  • Surgical Outcomes

Background:

  • Hepatitis B virus (HBV)-related liver disease outcomes post-transplantation have improved.
  • Prophylaxis against hepatitis C virus (HCV) recurrence remains a challenge.
  • Hepatocellular carcinoma (HCC) outcomes are predicted by Milan criteria.

Purpose of the Study:

  • To review advancements in liver transplantation outcomes.
  • To highlight challenges in post-transplant management and donor availability.

Main Methods:

  • Review of current literature on liver transplantation for viral hepatitis and HCC.
  • Analysis of prognostic indicators like MELD scores.
  • Evaluation of strategies for ABO-incompatible transplantation and donor recruitment.

Related Experiment Videos

Main Results:

  • Hepatitis B immune globulin and antivirals (e.g., lamivudine) have improved HBV outcomes.
  • Milan criteria predict acceptable outcomes for HCC.
  • MELD scores effectively predict survival on waiting lists and post-transplant.
  • Intraportal infusions may improve ABO-incompatible transplant outcomes.
  • Living donor complications occur in 12.4% of cases, emphasizing the need for more brain-dead donors.

Conclusions:

  • Significant progress in HBV-related liver transplantation, but HCV recurrence prophylaxis is needed.
  • MELD scores are crucial for predicting patient survival.
  • Addressing challenges in ABO-incompatible transplantation and increasing brain-dead donor supply are critical for improving overall liver transplant success.